Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...